Targeting mutant p53 protein and the tumor vasculature: An effective combination therapy for advanced breast tumors

Medicine & Life Sciences

• Mutant Proteins 100%
• 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one 69%
• Breast Neoplasms 59%
• Vascular Tissue Neoplasms 39%
• Neoplasms 30%
• Phospholipids 25%
• Therapeutics 15%
• Apoptosis 13%
• Vascular Endothelial Growth Factor A 12%
• Tumor Cell Line 7%
• Nude Mice 6%
• Heterografts 6%
• Therapeutic Uses 5%
• Cell Death 5%
• Perfusion 5%
• Ischemia 5%
• Poisons 5%
• Endothelial Cells 5%
• Monoclonal Antibodies 5%
• Epithelial Cells 5%
• Blood Vessels 4%
• Antibodies 3%
• Growth 3%
• In Vitro Techniques 3%
• Pharmaceutical Preparations 2%
• Proteins 2%